Description
+ Include: 27 videos, size: 6.03 GB
+ Target Audience: oncologist
+ Sample video: contact me for sample video
+ Information:
This 3-day conference is designed for medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician assistants (PA), advanced registered nurse practitioners (ARNP), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of review standard of care and new developments in cancer management. Residents in training and fellows from these specialties are encouraged to attend.
Topics in solid tumors and hematological malignancies will be reviewed and will include topics in breast cancer, lung cancer, gastrointestinal (GI) malignancies, gynecologic malignancies, genitourinary (GU) cancers, head and neck cancers, melanoma, and hematological malignancies such as multiple myeloma, CLL and non-Hodgkin’s lymphoma. There will also be a special session devoted to toxicity profiles, supportive care, and challenges in cancer therapy.
The areas of focus for this conference will include the current standards of care in the treatment of the aforementioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic, antiangiogenic, and immunotherapeutic agents.
Presentations from the latest national (AACR, ASCO, SABC, and ASH) and international forums (ESMO and WCLC) meetings will be discussed and guidelines of cancer care using a team approach will be emphasized. The participants in the conference will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care using a team approach but also engage in personal interaction with our panel of experts in these subjects during the questions and answers sessions.
+ Topics:
B-Cell Lymphomas Updates and Future Directions.mp4
Bone Marrow Transplant and CAR T Cell Therapy in Hematology Malignancies.mp4
Breast Cancer Immunotherapy.mp4
Cancer Screenings, Reducing Mortality.mp4
Cancer Survivorship A Long-Term Journey.mp4
CDK46, PIK3CA & PARP Inhibitors in MBCA.mp4
Chronic Lymphocytic Leukemias.mp4
Clinical Utility and Future indications of Liquid Biopsies in Lung Cancer.mp4
Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations.mp4
Endocrine Therapy in the Neoadjuvant & Adjuvant Setting.mp4
Gastric and Esophageal Cancer Updates.mp4
HER2-Driven Breast Cancer Current Status and Next Generation Therapeutics.mp4
How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC.mp4
Immunotherapy for Melanoma.mp4
Immunotherapy in Gynecologic Malignancies.mp4
Immunotherapy in Kidney & Bladder Tumors.mp4
Integrative Oncology Treatment Approaches for Stress in Cancer Patients and Survivors.mp4
Lung Cancer Neoadjuvant and Adjuvant Immunotherapy.mp4
Metastatic Colorectal Cancer Therapy.mp4
Multiple Myeloma.mp4
New approaches for Squamous Cell Carcinoma of Head and Neck and Thyroid Tumors.mp4
Predictive and Prognostic Biomarkers for IO Value of TMB, MSI, -PD-L1 and Others in Liquid and Solid Tumor Specimens.mp4
Proton Therapy and Novel Energy Approaches in Cancer Care.mp4
Stage III NSCLC Beyond the PACIFIC Novel Approaches.mp4
Systemic and Combined Therapy for Soft Tissue Sarcomas.mp4
Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12).mp4
Uncommon Mutations Fusions EGFRex20ins, RET, MET, Her2, NRG1.mp4
Reviews
There are no reviews yet.